View Resume/Cv - University of Pennsylvania LDI CHI | Center for ...
View Resume/Cv - University of Pennsylvania LDI CHI | Center for ...
View Resume/Cv - University of Pennsylvania LDI CHI | Center for ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Troxel, Andrea B., Sc.D. 26<br />
1. Abuabara K., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M.:<br />
Cause-specific mortality in patients with severe psoriasis: A cohort study using the<br />
general practice research database. (oral presentation). Society <strong>of</strong> Investigative<br />
Dermatology 2009.<br />
2. Azfar R.S., Neimann A.L., Shin D.B., Troxel A.B. and Gelfand J.M.: Risk <strong>of</strong><br />
cardiovascular mortality in patients with severe psoriasis. (poster presentation). Society<br />
<strong>for</strong> Investigative Dermatology 2009.<br />
3. Brose M.S., Troxel A.B., Redlinger M., Harklacker K., Redlinger C., Chalian A.A.,<br />
Flaherty K.T., Loevner L.A., Mandel S.J. and O'Dwyer P.J.: Effect <strong>of</strong> BRAF v600E on<br />
response to sorafenib in advanced thyroid cancer patients. (poster presentation).<br />
American Society <strong>of</strong> Clinical Oncology 2009.<br />
4. Cetnar J.P., Rosen M.A., Vaughn D.J., Haas N.B., Troxel A.B., Song H., Adluru G.,<br />
Flaherty K.T., O'Dwyer P.J. and Amaravadi R.K.: Phase II study <strong>of</strong> sorafenib and<br />
docetaxel in men with metastatic castration resistant prostate cancer (mCRPC). (poster<br />
presentation). American Society <strong>of</strong> Clinical Oncology 2009.<br />
5. Cheville A.L., Bas<strong>for</strong>d J., Troxel A.B. and Kornblith A.: Determinants <strong>of</strong> functional<br />
disability in stage IV breast cancer. (poster presentation). Society <strong>of</strong> Clinical Oncology<br />
2009.<br />
6. Dommasch E., Shin D., Troxel A.B., Margolis D.J., Chren M.M. and Gelfand J.M.:<br />
Reliability and validity <strong>of</strong> the Patient Report <strong>of</strong> Extent <strong>of</strong> Psoriasis Involvement<br />
(PREPI) <strong>for</strong> determining psoriasis severity. (poster presentation). Society <strong>for</strong><br />
Investigative Dermatology 2009.<br />
7. Kurd S.K., Troxel A.B. and Gelfand J.M.: The risk <strong>of</strong> depression in patients with<br />
psoriasis. (poster presentation). International Society <strong>for</strong> Pharmacoepidemiology 2009.<br />
8. Mehta N.N., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B. and Gelfand J.M.:<br />
Patients with severe psoriasis and no history <strong>of</strong> cardiovascular disease are at increased<br />
risk <strong>of</strong> cardiovascular mortality. (poster presentation). American Heart Association<br />
2009.<br />
9. Seminara N., Abuabara K., Shin D., Kimmel S., Margolis D.J., Troxel A.B. and<br />
Gelfand J.M.: Prevalence <strong>of</strong> psoriasis severity and predictive value <strong>of</strong> psoriasis codes<br />
in The Health Improvement Network (THIN)-‐ a population based study. (oral<br />
presentation). Society <strong>of</strong> Investigative Dermatology 2009.
Change language